Quest Diagnostics IncorporatedDGXNYSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+5.2%
5Y CAGR+5.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+5.2%/yr
vs +7.0%/yr prior
5Y CAGR
+5.3%/yr
Consistent
Acceleration
-1.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.51B | +13.3% |
| 2024 | $6.63B | +6.9% |
| 2023 | $6.20B | -3.9% |
| 2022 | $6.45B | -2.0% |
| 2021 | $6.58B | +13.4% |
| 2020 | $5.80B | +15.2% |
| 2019 | $5.04B | +2.3% |
| 2018 | $4.93B | +4.4% |
| 2017 | $4.72B | +2.2% |
| 2016 | $4.62B | - |